Skip to main content

Dr. Geraldine McGinty appointed senior associate dean for clinical affairs

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.

Around Cornell

Cancer vaccine improves outcomes in Lynch syndrome model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

Treatment with endothelial cells reverses emphysema in model

The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Research suggests how tumors become aggressive prostate cancer

The genetic changes that underlie an especially lethal type of prostate cancer, called neuroendocrine prostate cancer, have been revealed in a new study at Weill Cornell Medicine. Learning more about what causes this type of cancer could lead to new approaches for treating it.

Black patients with liver disease may face obstacles to transplants

Black patients who have chronic liver failure, also known as end-stage liver disease, are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study.

Identifying social determinants of health in Brooklyn

New research from NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health.

Exoplanets get a cosmic front-row seat to find backlit Earth

Astronomers have identified 2,034 nearby star-systems – within 326 light-years – that could find life on Earth by watching our pale blue dot cross our sun.

Cooperative Extension grant aims to vaccinate NYS’ vulnerable

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Weill Cornell launches $1.5B campaign to change medicine

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched a $1.5 billion campaign that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.